Professional Documents
Culture Documents
Evidence Summary: RHL Commentary by Pattinson RC
Evidence Summary: RHL Commentary by Pattinson RC
1. EVIDENCE SUMMARY
This Cochrane Review highlights an area that requires urgent research. The question of whether the use of an antibiotic as a prophylactic is beneficial in women with incomplete abortions cannot be answered because of a lack of adequate research. Only one trial (1), is included in this review as it was the only one that fulfilled the criteria of the reviewers; a second trial (2), was excluded owing to high losses to follow-up in the study. The trial included in the review found no difference in the rates of postabortion infection between those who received routine antibiotic prophylaxis and those who did not. The methodology was perfectly adequate.
years, nulligravidity, (especially if the patient reports two or more sex partners within a year), previous pelvic inflammatory disease (PID) or gonorrhoea, and untreated gonorrhoea, chlamydia, or bacterial vaginosis at the time of abortion. In a study at a large hospital serving a mainly semi-urban and rural black population in South Africa, 35% of women presenting themselves for a termination of pregnancy were diagnosed as having a sexually transmitted disease (4). 23% had chlamydia and 5% had gonorrhoea. It would be logical to assume in this population that most women presenting with an incomplete abortion would be regarded as high-risk for post abortion infection, even though there may not be clinical evidence of infection at the time of presentation. Should prophylactic antibiotics be used, a single dose of doxycycline or a two-dose regimen as described above would be feasible and inexpensive. Doxycycline would be preferred to other tetracyclines because it has a long half-life, less gastrointestinal side-effects and does not chelate to food or calcium.
2.5. Research
Urgent research is required to determine whether the use of prophylactic antibiotics in incomplete abortion is useful. A single dose of antibiotics used around the time of the evacuation of the uterus should be tested. Although it is unrealistic to expect it from individual randomized controlled trials, one would like to see data on more significant end points such as hysterectomy and mortality. It would also be useful to learn whether different in antibiotic regimes yield different results and whether the results are different in high-risk and low-risk subjects. Sources of support: MRC Maternal and Infant Health Care Strategies Research Unit, South Africa. Acknowledgement: None.
References
Seeras R. Evaluation of prophylactic use of tetracycline after evacuation in abortion in Harare Central Hospital. East African medical journal 1989;66:607-610. Prieto JA, Eriksen NL, Blanco JD. A randomised trial of prophylactic doxycycline for curettage in incomplete abortion. Obstetrics and gynecology 1995;85:692-696. Sawaya G, Grady D, Kerlikowske K, Grimes D.. E Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysisl. East African medical journal 1996;87:884-890. Fernandes L, Mahomed MF, Mazibuko DM, Hoosen AA. Sexually transmitted pathogens in women attending for termination of pregnancy. Geneeskunde 1998;40 (2):16-19.
This document should be cited as: Pattinson RC. Antibiotics for incomplete abortion: RHL commentary (last revised: 24 June 2002). The WHO Reproductive Health Library; Geneva: World Health Organization.